166 related articles for article (PubMed ID: 19627253)
1. Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging.
Matusiak Ł; Bieniek A; Szepietowski JC
Biomarkers; 2009 Sep; 14(6):432-7. PubMed ID: 19627253
[TBL] [Abstract][Full Text] [Related]
2. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
[TBL] [Abstract][Full Text] [Related]
3. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
[TBL] [Abstract][Full Text] [Related]
4. Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?
Matusiak L; Bieniek A; Szepietowski JC
Acta Derm Venereol; 2009 Nov; 89(6):601-3. PubMed ID: 19997690
[TBL] [Abstract][Full Text] [Related]
5. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors.
Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M
Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465
[TBL] [Abstract][Full Text] [Related]
6. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
Siemińska A
Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
[TBL] [Abstract][Full Text] [Related]
7. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
Zailaie MZ
Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
[TBL] [Abstract][Full Text] [Related]
8. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
[TBL] [Abstract][Full Text] [Related]
9. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.
Bargagli E; Bianchi N; Margollicci M; Olivieri C; Luddi A; Coviello G; Grosso S; Rottoli P
Scand J Clin Lab Invest; 2008; 68(6):479-83. PubMed ID: 18609101
[TBL] [Abstract][Full Text] [Related]
10. Circulating soluble interleukin-2 receptor level predicts remission in very early reactive arthritis.
Kuuliala A; Söderlin M; Kautiainen H; Repo H; Leirisalo-Repo M
Scand J Rheumatol; 2005; 34(5):372-5. PubMed ID: 16234184
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic significance of serum soluble interleukin 2 receptor in children with malignancies].
Bień E; Balcerska A; Ciesielski D
Wiad Lek; 2006; 59(1-2):10-5. PubMed ID: 16646285
[TBL] [Abstract][Full Text] [Related]
12. Painful hidradenitis suppurativa.
Smith HS; Chao JD; Teitelbaum J
Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus.
El-Shafey EM; El-Nagar GF; El-Bendary AS; Sabry AA; Selim AG
Iran J Kidney Dis; 2008 Apr; 2(2):80-5. PubMed ID: 19377213
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.
Canoui-Poitrine F; Revuz JE; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Bastuji-Garin S
J Am Acad Dermatol; 2009 Jul; 61(1):51-7. PubMed ID: 19406505
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
Alhusayen R; Shear NH
Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
[TBL] [Abstract][Full Text] [Related]
17. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
Esmann S; Dufour DN; Jemec GB
Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
[TBL] [Abstract][Full Text] [Related]
18. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
Hessam S; Sand M; Gambichler T; Bechara FG
J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study.
Brocard A; Knol AC; Khammari A; Dréno B
Dermatology; 2007; 214(4):325-7. PubMed ID: 17460404
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
